LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 90

Search options

  1. Article ; Online: Pediatric Medical Countermeasures: Antidotes and Cytokines for Radiological and Nuclear Incidents and Terrorism.

    Maciulewicz, Thom S / Kazzi, Ziad / Navis, Irene L / Nelsen, Gregory J / Cieslak, Theodore J / Newton, Christopher / Lin, Anna / West, Doneen J / Walter, Frank G

    Disaster medicine and public health preparedness

    2024  Volume 18, Page(s) e76

    Abstract: The war in Ukraine raises concerns for potential hazards of radiological and nuclear incidents. Children are particularly vulnerable in these incidents and may need pharmaceutical countermeasures, including antidotes and cytokines. Searches found no ... ...

    Abstract The war in Ukraine raises concerns for potential hazards of radiological and nuclear incidents. Children are particularly vulnerable in these incidents and may need pharmaceutical countermeasures, including antidotes and cytokines. Searches found no published study comparing pediatric indications and dosing among standard references detailing pediatric medications for these incidents. This study addresses this gap by collecting, tabulating, and disseminating this information to healthcare professionals caring for children. Expert consensus chose the following references to compare their pediatric indications and dosing of medical countermeasures for radiation exposure and internal contamination with radioactive materials:
    MeSH term(s) Humans ; Terrorism/statistics & numerical data ; Medical Countermeasures ; Antidotes/therapeutic use ; Child ; Cytokines ; Radioactive Hazard Release ; Ukraine ; Pediatrics/methods ; Pediatrics/standards ; Disaster Planning/methods
    Chemical Substances Antidotes ; Cytokines
    Language English
    Publishing date 2024-04-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2375268-3
    ISSN 1938-744X ; 1935-7893
    ISSN (online) 1938-744X
    ISSN 1935-7893
    DOI 10.1017/dmp.2024.35
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver.

    Fernández Moro, Carlos / Geyer, Natalie / Harrizi, Sara / Hamidi, Yousra / Söderqvist, Sara / Kuznyecov, Danyil / Tidholm Qvist, Evelina / Salmonson Schaad, Media / Hermann, Laura / Lindberg, Amanda / Heuchel, Rainer L / Martín-Bernabé, Alfonso / Dhanjal, Soniya / Navis, Anna C / Villard, Christina / Del Valle, Andrea C / Bozóky, Lorand / Sparrelid, Ernesto / Dirix, Luc /
    Strell, Carina / Östman, Arne / Schmierer, Bernhard / Vermeulen, Peter B / Engstrand, Jennie / Bozóky, Béla / Gerling, Marco

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 5024

    Abstract: A perimetastatic capsule is a strong positive prognostic factor in liver metastases, but its origin remains unclear. Here, we systematically quantify the capsule's extent and cellular composition in 263 patients with colorectal cancer liver metastases to ...

    Abstract A perimetastatic capsule is a strong positive prognostic factor in liver metastases, but its origin remains unclear. Here, we systematically quantify the capsule's extent and cellular composition in 263 patients with colorectal cancer liver metastases to investigate its clinical significance and origin. We show that survival improves proportionally with increasing encapsulation and decreasing tumor-hepatocyte contact. Immunostaining reveals the gradual zonation of the capsule, transitioning from benign-like NGFR
    MeSH term(s) Animals ; Mice ; Liver Neoplasms ; Hepatocytes ; Aggression ; Clinical Relevance
    Language English
    Publishing date 2023-08-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-40688-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: UHRF1 Licensed Self-Renewal of Active Adult Neural Stem Cells.

    Blanchart, Albert / Navis, Anna C / Assaife-Lopes, Natalia / Usoskin, Dmitry / Aranda, Sergi / Sontheimer, Jana / Ernfors, Patrik

    Stem cells (Dayton, Ohio)

    2018  Volume 36, Issue 11, Page(s) 1736–1751

    Abstract: Adult neurogenesis in the brain continuously seeds new neurons throughout life, but how homeostasis of adult neural stem cells (NSCs) is maintained is incompletely understood. Here, we demonstrate that the DNA methylation adapter ubiquitin-like, ... ...

    Abstract Adult neurogenesis in the brain continuously seeds new neurons throughout life, but how homeostasis of adult neural stem cells (NSCs) is maintained is incompletely understood. Here, we demonstrate that the DNA methylation adapter ubiquitin-like, containing PHD and RING finger domains-1 (UHRF1) is expressed in, and regulates proliferation of, the active but not quiescent pool of adult neural progenitor cells. Mice with a neural stem cell-specific deficiency in UHRF1 exhibit a massive depletion of neurogenesis resulting in a collapse of formation of new neurons. In the absence of UHRF1, NSCs unexpectedly remain in the cell cycle but with a 17-fold increased cell cycle length due to a failure of replication phase entry caused by promoter demethylation and derepression of Cdkn1a, which encodes the cyclin-dependent kinase inhibitor p21. UHRF1 does not affect the proportion progenitor cells active within the cell cycle but among these cells, UHRF1 is critical for licensing replication re-entry. Therefore, this study shows that a UHRF1-Cdkn1a axis is essential for the control of stem cell self-renewal and neurogenesis in the adult brain. Stem Cells 2018;36:1736-1751.
    MeSH term(s) Adult Stem Cells/metabolism ; Animals ; Humans ; Mice ; Neural Stem Cells/metabolism ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism
    Chemical Substances Nuclear Proteins ; Uhrf1 protein, mouse
    Language English
    Publishing date 2018-08-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1143556-2
    ISSN 1549-4918 ; 1066-5099
    ISSN (online) 1549-4918
    ISSN 1066-5099
    DOI 10.1002/stem.2889
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: p120-catenin-dependent collective brain infiltration by glioma cell networks.

    Gritsenko, Pavlo G / Atlasy, Nader / Dieteren, Cindy E J / Navis, Anna C / Venhuizen, Jan-Hendrik / Veelken, Cornelia / Schubert, Dirk / Acker-Palmer, Amparo / Westerman, Bart A / Wurdinger, Thomas / Leenders, William / Wesseling, Pieter / Stunnenberg, Hendrik G / Friedl, Peter

    Nature cell biology

    2020  Volume 22, Issue 1, Page(s) 97–107

    Abstract: Diffuse brain infiltration by glioma cells causes detrimental disease progression, but its multicellular coordination is poorly understood. We show here that glioma cells infiltrate the brain collectively as multicellular networks. Contacts between ... ...

    Abstract Diffuse brain infiltration by glioma cells causes detrimental disease progression, but its multicellular coordination is poorly understood. We show here that glioma cells infiltrate the brain collectively as multicellular networks. Contacts between moving glioma cells are adaptive epithelial-like or filamentous junctions stabilized by N-cadherin, β-catenin and p120-catenin, which undergo kinetic turnover, transmit intercellular calcium transients and mediate directional persistence. Downregulation of p120-catenin compromises cell-cell interaction and communication, disrupts collective networks, and both the cadherin and RhoA binding domains of p120-catenin are required for network formation and migration. Deregulating p120-catenin further prevents diffuse glioma cell infiltration of the mouse brain with marginalized microlesions as the outcome. Transcriptomics analysis has identified p120-catenin as an upstream regulator of neurogenesis and cell cycle pathways and a predictor of poor clinical outcome in glioma patients. Collective glioma networks infiltrating the brain thus depend on adherens junctions dynamics, the targeting of which may offer an unanticipated strategy to halt glioma progression.
    MeSH term(s) Adherens Junctions/metabolism ; Animals ; Brain/metabolism ; Brain/pathology ; Cadherins/metabolism ; Catenins/metabolism ; Cell Adhesion/physiology ; Cell Line, Tumor ; Down-Regulation/physiology ; Glioma/metabolism ; Glioma/pathology ; Phosphoproteins/metabolism ; Phosphorylation ; Delta Catenin
    Chemical Substances Cadherins ; Catenins ; Phosphoproteins ; Delta Catenin
    Language English
    Publishing date 2020-01-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1474722-4
    ISSN 1476-4679 ; 1465-7392
    ISSN (online) 1476-4679
    ISSN 1465-7392
    DOI 10.1038/s41556-019-0443-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.

    van Lith, Sanne A M / van Duijnhoven, Sander M J / Navis, Anna C / Leenders, William P J / Dolk, Edward / Wennink, Jos W H / van Nostrum, Cornelus F / van Hest, Jan C M

    Bioconjugate chemistry

    2017  Volume 28, Issue 2, Page(s) 539–548

    Abstract: Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer ... ...

    Abstract Conjugation of llama single domain antibody fragments (Variable Heavy chain domains of Heavy chain antibodies, VHHs) to diagnostic or therapeutic nanoparticles, peptides, proteins, or drugs offers many opportunities for optimized targeted cancer treatment. Currently, mostly nonspecific conjugation strategies or genetic fusions are used that may compromise VHH functionality. In this paper we present a versatile modular approach for bioorthogonal VHH modification and conjugation. First, sortase A mediated transPEGylation is used for introduction of a chemical click moiety. The resulting clickable VHHs are then used for conjugation to other groups employing the Cu
    MeSH term(s) Alkynes/chemistry ; Aminoacyltransferases/metabolism ; Animals ; Azides/chemistry ; Bacterial Proteins/metabolism ; Camelids, New World/immunology ; Click Chemistry/methods ; Cycloaddition Reaction/methods ; Cysteine Endopeptidases/metabolism ; Immunoconjugates/chemistry ; Immunoconjugates/immunology ; Immunoconjugates/metabolism ; Immunoglobulin Heavy Chains/chemistry ; Immunoglobulin Heavy Chains/immunology ; Immunoglobulin Heavy Chains/metabolism ; Nanoparticles/chemistry ; Polyethylene Glycols/chemistry ; Polyethylene Glycols/metabolism ; Single-Domain Antibodies/chemistry ; Single-Domain Antibodies/immunology ; Single-Domain Antibodies/metabolism
    Chemical Substances Alkynes ; Azides ; Bacterial Proteins ; Immunoconjugates ; Immunoglobulin Heavy Chains ; Single-Domain Antibodies ; Polyethylene Glycols (30IQX730WE) ; Aminoacyltransferases (EC 2.3.2.-) ; sortase A (EC 2.3.2.-) ; Cysteine Endopeptidases (EC 3.4.22.-)
    Language English
    Publishing date 2017-02-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1024041-x
    ISSN 1520-4812 ; 1043-1802
    ISSN (online) 1520-4812
    ISSN 1043-1802
    DOI 10.1021/acs.bioconjchem.6b00638
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma.

    Esmaeili, Morteza / Hamans, Bob C / Navis, Anna C / van Horssen, Remco / Bathen, Tone F / Gribbestad, Ingrid S / Leenders, William P / Heerschap, Arend

    Cancer research

    2014  Volume 74, Issue 17, Page(s) 4898–4907

    Abstract: Many patients with glioma harbor specific mutations in the isocitrate dehydrogenase gene IDH1 that associate with a relatively better prognosis. IDH1-mutated tumors produce the oncometabolite 2-hydroxyglutarate. Because IDH1 also regulates several ... ...

    Abstract Many patients with glioma harbor specific mutations in the isocitrate dehydrogenase gene IDH1 that associate with a relatively better prognosis. IDH1-mutated tumors produce the oncometabolite 2-hydroxyglutarate. Because IDH1 also regulates several pathways leading to lipid synthesis, we hypothesized that IDH1-mutant tumors have an altered phospholipid metabolite profile that would impinge on tumor pathobiology. To investigate this hypothesis, we performed (31)P-MRS imaging in mouse xenograft models of four human gliomas, one of which harbored the IDH1-R132H mutation. (31)P-MR spectra from the IDH1-mutant tumor displayed a pattern distinct from that of the three IDH1 wild-type tumors, characterized by decreased levels of phosphoethanolamine and increased levels of glycerophosphocholine. This spectral profile was confirmed by ex vivo analysis of tumor extracts, and it was also observed in human surgical biopsies of IDH1-mutated tumors by (31)P high-resolution magic angle spinning spectroscopy. The specificity of this profile for the IDH1-R132H mutation was established by in vitro (31)P-NMR of extracts of cells overexpressing IDH1 or IDH1-R132H. Overall, our results provide evidence that the IDH1-R132H mutation alters phospholipid metabolism in gliomas involving phosphoethanolamine and glycerophosphocholine. These new noninvasive biomarkers can assist in the identification of the mutation and in research toward novel treatments that target aberrant metabolism in IDH1-mutant glioma.
    MeSH term(s) Animals ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Ethanolamines/metabolism ; Female ; Glioma/genetics ; Glioma/metabolism ; Humans ; Isocitrate Dehydrogenase/genetics ; Magnetic Resonance Spectroscopy/methods ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Mutation/genetics ; Phospholipids/genetics ; Phospholipids/metabolism
    Chemical Substances Biomarkers, Tumor ; Ethanolamines ; Phospholipids ; phosphorylethanolamine (78A2BX7AEU) ; Isocitrate Dehydrogenase (EC 1.1.1.41) ; IDH1 protein, human (EC 1.1.1.42.)
    Language English
    Publishing date 2014-09-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-14-0008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.

    Sol, Nik / In 't Veld, Sjors G J G / Vancura, Adrienne / Tjerkstra, Maud / Leurs, Cyra / Rustenburg, François / Schellen, Pepijn / Verschueren, Heleen / Post, Edward / Zwaan, Kenn / Ramaker, Jip / Wedekind, Laurine E / Tannous, Jihane / Ylstra, Bauke / Killestein, Joep / Mateen, Farrah / Idema, Sander / de Witt Hamer, Philip C / Navis, Anna C /
    Leenders, William P J / Hoeben, Ann / Moraal, Bastiaan / Noske, David P / Vandertop, W Peter / Nilsson, R Jonas A / Tannous, Bakhos A / Wesseling, Pieter / Reijneveld, Jaap C / Best, Myron G / Wurdinger, Thomas

    Cell reports. Medicine

    2020  Volume 1, Issue 7, Page(s) 100101

    Abstract: Tumor-educated platelets (TEPs) are potential biomarkers for cancer diagnostics. We employ TEP-derived RNA panels, determined ... ...

    Abstract Tumor-educated platelets (TEPs) are potential biomarkers for cancer diagnostics. We employ TEP-derived RNA panels, determined by
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Algorithms ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Blood Platelets/metabolism ; Blood Platelets/pathology ; Brain Neoplasms/diagnosis ; Brain Neoplasms/genetics ; Brain Neoplasms/mortality ; Brain Neoplasms/surgery ; Case-Control Studies ; Disease Progression ; Glioblastoma/diagnosis ; Glioblastoma/genetics ; Glioblastoma/mortality ; Glioblastoma/surgery ; Humans ; Middle Aged ; Monitoring, Physiologic/methods ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/genetics ; Multiple Sclerosis/pathology ; Neoplasm Metastasis ; RNA Splicing ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; ROC Curve ; Survival Analysis ; Tumor Microenvironment/genetics
    Chemical Substances Biomarkers, Tumor ; RNA, Neoplasm
    Language English
    Publishing date 2020-10-20
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2666-3791
    ISSN (online) 2666-3791
    DOI 10.1016/j.xcrm.2020.100101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models

    Navis, Anna C / Hamans, Bob C / Claes, An / Heerschap, Arend / Jeuken, Judith WM / Wesseling, Pieter / Leenders, William PJ

    Journal of pathology. 2011 Apr., v. 223, no. 5

    2011  

    Abstract: Currently available compounds that interfere with VEGF-A signalling effectively inhibit angiogenesis in gliomas, but influence diffuse infiltrative growth to a much lesser extent. Development of a functional tumour vascular bed not only involves VEGF-A ... ...

    Abstract Currently available compounds that interfere with VEGF-A signalling effectively inhibit angiogenesis in gliomas, but influence diffuse infiltrative growth to a much lesser extent. Development of a functional tumour vascular bed not only involves VEGF-A but also requires platelet-derived growth factor receptor-β (PDGFRβ), which induces maturation of tumour blood vessels. Therefore, we tested whether combined inhibition of VEGFR and PDGFRβ increases therapeutic benefit in the orthotopic glioma xenograft models E98 and E473, both displaying the diffuse infiltrative growth that is characteristically observed in most human gliomas. We used bevacizumab and vandetanib as VEGF(R) inhibitors, and sunitinib to additionally target PDGFRβ. We show that combination therapy of sunitinib and vandetanib does not improve therapeutic efficacy compared to treatment with sunitinib, vandetanib or bevacizumab alone. Furthermore, all compounds induced reduction of vessel leakage in compact E98 tumour areas, resulting in decreased detectability of these mostly infiltrative xenografts in Gd-DTPA-enhanced MRI scans. These data show that inhibition of VEGF signalling cannot be optimized by additional PDGFR inhibition and support the concept that diffuse infiltrative areas in gliomas are resistant to anti-angiogenic therapy. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
    Language English
    Dates of publication 2011-04
    Size p. 626-634.
    Publishing place John Wiley & Sons, Ltd.
    Document type Article
    ZDB-ID 3119-7
    ISSN 1096-9896 ; 0022-3417
    ISSN (online) 1096-9896
    ISSN 0022-3417
    DOI 10.1002/path.2836
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.

    Vlenterie, Myrella / Hillebrandt-Roeffen, Melissa H S / Schaars, Esther W M / Flucke, Uta E / Fleuren, Emmy D G / Navis, Anna C / Leenders, William P J / Versleijen-Jonkers, Yvonne M H / van der Graaf, Winette T A

    Annals of surgical oncology

    2016  Volume 23, Issue 9, Page(s) 2745–2752

    Abstract: Background: In synovial sarcomas alterations in the cyclin D1-CDK4/6-Rb axis have been described. Also, β-catenin, a cyclin D1 regulator, is often overexpressed. Additionally, studies have shown that the t(X;18) translocation influences tumor behavior ... ...

    Abstract Background: In synovial sarcomas alterations in the cyclin D1-CDK4/6-Rb axis have been described. Also, β-catenin, a cyclin D1 regulator, is often overexpressed. Additionally, studies have shown that the t(X;18) translocation influences tumor behavior partly through cyclin D1 activation. We investigated how alterations in the cyclin D1-CDK4/6-Rb axis impact prognosis and studied effects of targeting this axis with the CDK4/6 inhibitor palbociclib.
    Methods: Synovial sarcoma samples (n = 43) were immunohistochemically stained for β-catenin, cyclin D1, p16, p21, p27, Rb, and phospho-Rb. Fluorescent in situ hybridization (FISH) was performed to detect CCND1 amplification or translocation. In 4 synovial sarcoma cell lines sensitivity to palbociclib was investigated using cell viability assays, and effects on the sensitive cell lines were evaluated on protein level and by cell cycle arrest.
    Results: Expression of nuclear phospho-Rb and nuclear β-catenin in the patient samples was associated with poor survival. FISH showed a sporadic translocation of CCND1 in a subset of tumors. An 8-fold CCND1 amplification was found in 1 cell line, but not in the patient samples investigated. Palbociclib effectively inhibited Rb-phosphorylation in 3 cell lines, resulting in an induction of a G1 arrest and proliferation block.
    Conclusions: In this series nuclear phospho-Rb and nuclear β-catenin expression were negative prognostic factors. In vitro data suggest that palbociclib may be a potential treatment for a subset of synovial sarcoma patients. Whether this effect can be enhanced by combination treatment deserves further preclinical investigations.
    MeSH term(s) Adolescent ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cyclin D1/genetics ; Cyclin-Dependent Kinase 4/antagonists & inhibitors ; Cyclin-Dependent Kinase 6/antagonists & inhibitors ; Cyclin-Dependent Kinase Inhibitor p16/metabolism ; Cyclin-Dependent Kinase Inhibitor p21/metabolism ; Cyclin-Dependent Kinase Inhibitor p27/metabolism ; Female ; G1 Phase Cell Cycle Checkpoints/drug effects ; Humans ; Immunohistochemistry ; Male ; Phosphorylation/drug effects ; Piperazines/pharmacology ; Piperazines/therapeutic use ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Retinoblastoma Protein/metabolism ; Sarcoma, Synovial/drug therapy ; Sarcoma, Synovial/genetics ; Sarcoma, Synovial/metabolism ; Survival Rate ; Young Adult ; beta Catenin/metabolism
    Chemical Substances Antineoplastic Agents ; CCND1 protein, human ; CDKN1A protein, human ; Cyclin-Dependent Kinase Inhibitor p16 ; Cyclin-Dependent Kinase Inhibitor p21 ; Piperazines ; Pyridines ; Retinoblastoma Protein ; beta Catenin ; Cyclin D1 (136601-57-5) ; Cyclin-Dependent Kinase Inhibitor p27 (147604-94-2) ; Cyclin-Dependent Kinase 4 (EC 2.7.11.22) ; Cyclin-Dependent Kinase 6 (EC 2.7.11.22) ; palbociclib (G9ZF61LE7G)
    Language English
    Publishing date 2016-06-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1200469-8
    ISSN 1534-4681 ; 1068-9265
    ISSN (online) 1534-4681
    ISSN 1068-9265
    DOI 10.1245/s10434-016-5341-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor Plasticity.

    van den Heuvel, Corina N A M / Navis, Anna C / de Bitter, Tessa / Amiri, Houshang / Verrijp, Kiek / Heerschap, Arend / Rex, Karen / Dussault, Isabelle / Caenepeel, Sean / Coxon, Angela / Span, Paul N / Wesseling, Pieter / Hendriks, Wiljan / Leenders, William P J

    Molecular cancer research : MCR

    2017  Volume 15, Issue 11, Page(s) 1587–1597

    Abstract: The receptor tyrosine kinase (RTK) MET represents a promising tumor target in a subset of glioblastomas. Most RTK inhibitors available in the clinic today, including those inhibiting MET, affect multiple targets simultaneously. Previously, it was ... ...

    Abstract The receptor tyrosine kinase (RTK) MET represents a promising tumor target in a subset of glioblastomas. Most RTK inhibitors available in the clinic today, including those inhibiting MET, affect multiple targets simultaneously. Previously, it was demonstrated that treatment with cabozantinib (MET/VEGFR2/RET inhibitor) prolonged survival of mice carrying orthotopic patient-derived xenografts (PDX) of the MET-addicted glioblastoma model E98, yet did not prevent development of recurrent and cabozantinib-resistant tumors. To exclude VEGFR2 inhibition-inflicted blood-brain barrier normalization and diminished tumor distribution of the drug, we have now investigated the effects of the novel MET-selective inhibitor Compound A in the orthotopic E98 xenograft model.
    MeSH term(s) Aminopyridines/administration & dosage ; Aminopyridines/pharmacology ; Animals ; Brain Neoplasms/drug therapy ; Brain Neoplasms/genetics ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic/drug effects ; Glioma/drug therapy ; Glioma/genetics ; HT29 Cells ; Humans ; Mice ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/pharmacology ; Pyrazoles/administration & dosage ; Pyrazoles/pharmacology ; Sequence Analysis, RNA/methods ; Small Molecule Libraries/administration & dosage ; Small Molecule Libraries/pharmacology ; Xenograft Model Antitumor Assays
    Chemical Substances 1-(2-hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide ; Aminopyridines ; Protein Kinase Inhibitors ; Pyrazoles ; Small Molecule Libraries
    Language English
    Publishing date 2017-07-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2098788-2
    ISSN 1557-3125 ; 1541-7786
    ISSN (online) 1557-3125
    ISSN 1541-7786
    DOI 10.1158/1541-7786.MCR-17-0177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top